Heading: |
Parkinson's Disease: Medical Treatments |
Question ID: |
1786224 |
UIN: |
39425 |
House: |
Commons |
Date tabled: |
2025-03-19 |
Asking Member ID: |
4131 |
Asking Member display name: |
Jim Shannon
|
Asking Member handle: |
jimshannonmp
|
Asking Member Twitter reference: |
@jimshannonmp
|
Member interest: |
false |
Question text: |
To ask the Secretary of State for Health and Social Care, what steps his Department is taking with devolved governments to help ensure the equal provision of NICE-approved treatments across the UK for (a) advanced and (b) complex Parkinson’s disease. |
Is named day: |
false |
Date of holding answer: |
|
Date answered: |
2025-03-25 |
Date answer corrected: |
|
Is holding answer: |
false |
Is correcting answer: |
false |
Answering Member ID: |
4444 |
Answering Member display name: |
Karin Smyth
|
Answering Member handle: |
karinsmyth
|
Answering Member Twitter reference: |
@karinsmyth
|
Correcting Member ID: |
|
Correcting Member display name: |
|
Correcting Member handle: |
|
Correcting Member Twitter reference: |
|
Answer text: |
The National Institute for Health and Care Excellence (NICE) makes recommendations on whether new medicines should be routinely funded by the National Health Service in England. Health is a devolved matter and decisions on the availability of medicines is... |
Original answer text: |
|
Comparable answer text: |
|
Answering body ID: |
17 |
Answering body name: |
Department of Health and Social Care |
Tweeted: |
true |